Full-Time

Vice President

Clinical Development

Posted on 11/20/2024

Generate Biomedicines

Generate Biomedicines

201-500 employees

Generates novel medicines using generative biology

AI & Machine Learning
Biotechnology
Healthcare

Senior

Cambridge, MA, USA

Role based out of headquarters in Somerville, MA.

Category
Healthcare Administration & Support
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • An M.D. degree with at least 7+ years of experience in clinical practice and drug development.
  • Experience in both early and late stage drug development including at least one experience in participating in a registrational study in immunology with associated regulatory interactions.
  • Experience in the respiratory field of immunology is preferred.
  • A documented track record of leadership while in the pharmaceutical industry, recognized for leadership in their field.
  • A patient-first attitude in trial design and execution.
  • Experience in drug development in oncology is preferred but not required.
  • Willingness to learn deeply about and develop drugs outside of their stated area of expertise.
  • Experience in small and large companies is preferred but not required.
  • A record of consistent professionalism, particularly when under pressure.
  • A willingness to make thoughtful decisions swiftly with limited data.
  • Strong organizational skills with an ability to work on multiple projects at various stages, concurrently.
  • High standards for themselves, colleagues and reports. Willingness to have difficult conversations for the sake of advancing company strategy and patient well-being.
  • Open-mindedness and creativity to new methods and bold strategies.
Responsibilities
  • Build and lead the clinical research function, which includes clinical directors, clinical scientists and clinical operations.
  • Serve as program lead for Generate’s late stage immunology asset or assets.
  • Hands-on involvement in planning and execution of Generate’s clinical trials.
  • Plan for and direct internal and external resources to achieve company goals in a swift, high quality and compliant manner.
  • Design and oversee clinical studies from Phase 1 through to registration. Know the details of each study and its participants and disseminate knowledge internally to enable decision-making.
  • Deep knowledge of therapeutic areas under study, including emerging data in the field.
  • Identify and foster productive relationships with investigators, including key opinion leaders, participating in Generate clinical trials.
  • Ensure smooth communication and collaboration between organizations and individuals involved in research at Generate, with particularly close attention to Preclinical Drug Discovery and the CMC/Quality organizations.
  • Represent Generate externally at conferences and with other external parties such as partners, CROs, collaborators and investors.
  • Foster a safe, inclusive work environment. Support the personal and career development goals of their reports.
Generate Biomedicines

Generate Biomedicines

View

Generate Biomedicines focuses on creating new medicines using a method called generative biology, which combines machine learning and biological engineering. This approach involves analyzing millions of proteins to learn how nature encodes their functions, allowing the company to design medicines with specific therapeutic effects. The main product, The Generate Platform, enables the rapid production of medicines across various therapeutic areas, significantly improving the drug discovery process compared to traditional methods. Unlike its competitors, Generate Biomedicines emphasizes a proactive and efficient approach to medicine creation, aiming to democratize access to biotherapeutics. The company's goal is to expand its capabilities in generating novel medicines, having already produced and tested 42,000 proteins.

Company Stage

Series C

Total Funding

$674.1M

Headquarters

Somerville, Massachusetts

Founded

2018

Growth & Insights
Headcount

6 month growth

0%

1 year growth

11%

2 year growth

37%
Simplify Jobs

Simplify's Take

What believers are saying

  • The recent $273M Series C financing round provides substantial capital to advance their generative AI pipeline and clinical programs.
  • Expansion of the leadership team with experienced professionals like Rupert Vessey, Nancy Simonian, and Kym White strengthens the company's strategic direction and operational capabilities.
  • Publication of the Chroma model in Nature highlights the company's innovative contributions to protein therapeutics, enhancing its reputation in the scientific community.

What critics are saying

  • The reliance on cutting-edge generative AI and machine learning technologies may face regulatory and adoption challenges in the conservative pharmaceutical industry.
  • Rapid expansion and scaling efforts, including new hires and leadership changes, could lead to integration and cultural challenges.

What makes Generate Biomedicines unique

  • Generate Biomedicines leverages generative biology and machine learning to create medicines on demand, a significant departure from traditional drug discovery methods.
  • The Generate Platform's ability to produce novel medicines across multiple therapeutic areas with high speed and success rates sets it apart from competitors.
  • Their focus on understanding the rules by which nature encodes function to design new proteins is a unique approach in the biotechnology sector.

Help us improve and share your feedback! Did you find this helpful?